{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:57:47Z","timestamp":1789761467061,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.tox.2016.06.015","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T15:27:22Z","timestamp":1466868442000},"page":"29-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model"],"prefix":"10.1016","volume":"359-360","author":[{"given":"Samar O.","family":"El-Ganainy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Mohy El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman S.","family":"El-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.06.015_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: a review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.tox.2016.06.015_bib0010","series-title":"Etiology and Therapeutic Approach to Elevated Lactate Levels","first-page":"1127","author":"Andersen","year":"2013"},{"key":"10.1016\/j.tox.2016.06.015_bib0015","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2016.06.015_bib0020","series-title":"Effects of Coenzyme Q10 on Statin-induced Myopathy: a Meta-analysis of Randomized Controlled Trials","first-page":"24","author":"Banach","year":"2015"},{"key":"10.1016\/j.tox.2016.06.015_bib0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/biof.5520090222","article-title":"Coenzyme Q_{10} administration and its potential for treatment of neurodegenerative diseases","volume":"9","author":"Beal","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.tox.2016.06.015_bib0030","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tox.2016.06.015_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00204-014-1378-4","article-title":"Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo","volume":"90","author":"Bonifacio","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.06.015_bib0040","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1152\/japplphysiol.00107.2011","article-title":"Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress","volume":"111","author":"Bouitbir","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0045","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0050","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1089\/scd.2012.0604","article-title":"Coenzyme Q10 restores amyloid beta-inhibited proliferation of neural stem cells by activating the PI3K pathway","volume":"22","author":"Choi","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.tox.2016.06.015_bib0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","article-title":"Biochemical functions of coenzyme Q10","volume":"20","author":"Crane","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.tox.2016.06.015_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.1996.04178.x","article-title":"Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate\/pyruvate ratio","volume":"42","author":"De Pinieux","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.06.015_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/jappl.1996.80.1.261","article-title":"Composition and size of type I, IIA, IID\/X, and IIB fibers and citrate synthase activity of rat muscle","volume":"80","author":"Delp","year":"1996","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0070","doi-asserted-by":"crossref","first-page":"C1208","DOI":"10.1152\/ajpcell.00226.2006","article-title":"Statin-induced apoptosis and skeletal myopathy","volume":"291","author":"Dirks","year":"2006","journal-title":"Am. J. Physiol.\u2014Cell Physiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0075","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1242\/jeb.017640","article-title":"Scaling of muscle architecture and fiber types in the rat hindlimb","volume":"211","author":"Eng","year":"2008","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.tox.2016.06.015_bib0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-012-0074-6","article-title":"Molecular and cellular mechanisms of skeletal muscle atrophy: an update","volume":"3","author":"Fanzani","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tox.2016.06.015_bib0085","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tox.2016.06.015_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02576234","article-title":"Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits","volume":"193","author":"Fukami","year":"1993","journal-title":"Res. Exp. Med. (Berl.)"},{"key":"10.1016\/j.tox.2016.06.015_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pbb.2011.08.007","article-title":"Antinociception induced by atorvastatin in different pain models","volume":"100","author":"Garcia","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tox.2016.06.015_bib0100","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.tox.2016.06.015_bib0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0110","first-page":"3940","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity","volume":"117","author":"Hanai","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2016.06.015_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2042098612439884","article-title":"Safety of statins: an update","volume":"3","author":"Hu","year":"2012","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.tox.2016.06.015_bib0120","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","article-title":"Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes","volume":"55","author":"Huynh","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tox.2016.06.015_bib0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1152\/jappl.1980.48.3.523","article-title":"Muscle respiratory capacity and fiber type as determinants of the lactate threshold","volume":"48","author":"Ivy","year":"1980","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0130","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00018-006-6235-z","article-title":"Toxicity of statins on rat skeletal muscle mitochondria","volume":"63","author":"Kaufmann","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tox.2016.06.015_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1006481423298","article-title":"Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma","volume":"19","author":"Kim","year":"2001","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.tox.2016.06.015_bib0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Laaksonen","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/biof.5520250116","article-title":"Treatment of statin adverse effects with supplemental coenzyme Q10 and statin drug discontinuation","volume":"25","author":"Langsjoen","year":"2005","journal-title":"Biofactors"},{"key":"10.1016\/j.tox.2016.06.015_bib0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.stem.2010.11.028","article-title":"Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K\/Akt-dependant manner","volume":"8","author":"Le Belle","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tox.2016.06.015_bib0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.106.118331","article-title":"Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum\/mitochondria Ca2+-release system","volume":"321","author":"Liantonio","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.06.015_bib0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/MCB.24.2.730-740.2004","article-title":"Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases","volume":"24","author":"Majewski","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tox.2016.06.015_bib0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.2008.164699","article-title":"Blunted Akt\/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy","volume":"587","author":"Mallinson","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/138945010790031018","article-title":"Coenzyme Q10 in neuromuscular and neurodegenerative disorders","volume":"11","author":"Mancuso","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.tox.2016.06.015_bib0180","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.bbamcr.2011.07.019","article-title":"Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt","volume":"1813","author":"Mullen","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Res."},{"key":"10.1016\/j.tox.2016.06.015_bib0185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02002711","article-title":"Clinical presentations and laboratory investigations in respiratory chain deficiency","volume":"155","author":"Munnich","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.tox.2016.06.015_bib0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1152\/japplphysiol.01362.2011","article-title":"Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance","volume":"113","author":"Muraki","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/taap.1998.8491","article-title":"Myopathy induced by HMG\u2013CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study","volume":"152","author":"Nakahara","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2016.06.015_bib0200","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/jcp.2004.015958","article-title":"Statin precipitated lactic acidosis?","volume":"57","author":"Neale","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tox.2016.06.015_bib0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2009.08.651","article-title":"Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER)","volume":"105","author":"Nicholls","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1939-4640.2005.tb02865.x","article-title":"Atorvastatin and male infertility: is there a link?","volume":"26","author":"Niederberger","year":"2005","journal-title":"J. Androl."},{"key":"10.1016\/j.tox.2016.06.015_bib0215","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bcp.2003.08.011","article-title":"Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes","volume":"66","author":"Nishimoto","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2016.06.015_bib0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phrs.2014.04.012","article-title":"Statins and skeletal muscles toxicity: from clinical trials to everyday practice","volume":"88","author":"Norata","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tox.2016.06.015_bib0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High\u00e4dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.06.015_bib0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellsig.2007.07.010","article-title":"PKB and the mitochondria: aKTing on apoptosis","volume":"20","author":"Parcellier","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tox.2016.06.015_bib0235","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0022-3565(25)12209-X","article-title":"Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers","volume":"275","author":"Pierno","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.06.015_bib0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","article-title":"Managing the underestimated risk of statin-associated myopathy","volume":"159","author":"Rallidis","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tox.2016.06.015_bib0245","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/toxsci\/kfi305","article-title":"Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity","volume":"88","author":"Seachrist","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.06.015_bib0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/00498250802585539","article-title":"Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy","volume":"39","author":"Sidaway","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2016.06.015_bib0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clinthera.2007.02.008","article-title":"Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy","volume":"29","author":"Silva","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tox.2016.06.015_bib0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tox.2016.06.015_bib0265","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0022-3565(25)24759-0","article-title":"HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies","volume":"257","author":"Smith","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.06.015_bib0270","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.mito.2007.03.006","article-title":"Coenzyme Q, oxidative stress and aging","volume":"7","author":"Sohal","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tox.2016.06.015_bib0275","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.freeradbiomed.2005.08.037","article-title":"Effect of coenzyme Q 10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice","volume":"40","author":"Sohal","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2016.06.015_bib0280","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tox.2016.06.015_bib0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.12.016","article-title":"A randomized trial of Coenzyme Q10 in patients with confirmed statin myopathy","volume":"238","author":"Taylor","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tox.2016.06.015_bib0290","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1734-1140(11)70601-6","article-title":"Statin-induced myopathies","volume":"63","author":"Tomaszewski","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.tox.2016.06.015_bib0295","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1096\/fj.11-184218","article-title":"Effects of myosin heavy chain (MHC) plasticity induced by HMGCoA-reductase inhibition on skeletal muscle functions","volume":"25","author":"Trapani","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.tox.2016.06.015_bib0300","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1002\/mnfr.201100147","article-title":"Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK\/PKC\/NADPH oxidase signaling pathway","volume":"55","author":"Tsai","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.tox.2016.06.015_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.04.009","article-title":"Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis","volume":"711","author":"Vaughan","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2016.06.015_bib0310","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00005072-199309000-00012","article-title":"Experimental lovastatin myopathy","volume":"52","author":"Waclawik","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tox.2016.06.015_bib0315","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/01926230590908213","article-title":"Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity","volume":"33","author":"Westwood","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.06.015_bib0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0192623307311412","article-title":"Rosuvastatin: characterization of induced myopathy in the rat","volume":"36","author":"Westwood","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.06.015_bib0325","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1073\/pnas.87.22.8928","article-title":"Lovastatin decreases coenzyme Q levels in rats","volume":"87","author":"Willis","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tox.2016.06.015_bib0330","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/emboj.2010.292","article-title":"ROS\u2010mediated amplification of AKT\/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3-\/- mice","volume":"29","author":"Yalcin","year":"2010","journal-title":"EMBO J."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16301135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16301135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:32:30Z","timestamp":1759534350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16301135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":66,"alternative-id":["S0300483X16301135"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.06.015","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}